SANTA ROSA, Calif.--(BUSINESS WIRE)--Keysight Technologies, Inc. (NYSE: KEYS) introduced a new portfolio of scale-up validation solutions designed to help artificial intelligence (AI) data center ...
Ultra‑Sensitive, Non‑Invasive Surveillance Solution Expected to Launch Commercially in the U.S. in 2027 as Part of CareDx’s Transplant+ Precision Medicine Portfolio BRISBANE, Calif., February 12, 2026 ...
The evidence that humans are causing climate change, with drastic consequences for life on the planet, is overwhelming. Experts began raising the alarm about global warming in 1979, a change now ...
Ultra‑Sensitive, Non‑Invasive Surveillance Solution Expected to Launch Commercially in the U.S. in 2027 as Part of CareDx’s Transplant+ Precision Medicine Portfolio CareDx, Inc. (Nasdaq: CDNA) — The ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果